Stephen C. Ekker, Ph.D. (@scekker) 's Twitter Profile
Stephen C. Ekker, Ph.D.

@scekker

Entrepreneur scientist. ZebrafishRcool. Moving innovation at UTAustin, Dell Med, Tx Health Catalyst. Active with LEAH Labs, LifEngine Tech, Forjazul. Posts=mine

ID: 156611885

linkhttps://www.linkedin.com/in/stephen-ekker/ calendar_today17-06-2010 11:53:06

9,9K Tweet

2,2K Followers

1,1K Following

@jason (@jason) 's Twitter Profile Photo

This is crazy, if true Greg Abbott Under no circumstances should tax payer money be used to increase the bags of crypto insiders If Texans want crypto exposure they can buy it on robinhood or coin base right now

Luiz Gustavo Dubois (@gustavodubois) 's Twitter Profile Photo

this is really inspiring science! First map of human brain mitochondria is ‘groundbreaking’ achievement nature.com/articles/d4158…

Stephen C. Ekker, Ph.D. (@scekker) 's Twitter Profile Photo

This is a truly cautionary tale. First, Dr Marks has my full respect. But despite his leadership, the FDA made only modest functional changes. His departure leaves a major scientific gap while the core problem - the calcified structure - remains.

Stephen C. Ekker, Ph.D. (@scekker) 's Twitter Profile Photo

Setting positive vibes all around! And 𝐃𝐚𝐯𝐢𝐝 𝐁𝐫𝐢𝐧 the question of Sundiver or Uplift? The answer is - yes! Sundiver as a movie, Uplift as a series. CGI can bring these awesome aliens visually to life!

Health Supernova (@healthsupernova) 's Twitter Profile Photo

#HealthSupernova hits ATX for the first time June 12 🧬 Bold ideas. Breakthrough tech. Unmatched networking. 🌟 Founders, investors & researchers will be in the room, ready to connect and build what’s next — will you be there? 🎟️ Tickets are going fast! hubs.ly/Q03g_DHD0

#HealthSupernova hits ATX for the first time June 12 🧬

Bold ideas. Breakthrough tech. Unmatched networking. 🌟

Founders, investors & researchers will be in the room, ready to connect and build what’s next — will you be there?

🎟️ Tickets are going fast! hubs.ly/Q03g_DHD0
FiorLAB (@ritafior) 's Twitter Profile Photo

📣🥳Check our new paper npj Journals Precision Oncology! We show 100% concordance (18/18) between BREAST CANCER 🐟zAvatars and actual patient responses! This work was spearheaded by very talented-magic hands post-doc Raquel Mendes👉 rdcu.be/egJ4z ChampalimaudF

📣🥳Check our new paper <a href="/Nature_NPJ/">npj Journals</a> Precision Oncology! We show 100% concordance (18/18) between BREAST CANCER 🐟zAvatars and actual patient responses! This work was spearheaded by very talented-magic hands post-doc Raquel Mendes👉 rdcu.be/egJ4z 
<a href="/ChampalimaudF/">ChampalimaudF</a>
Stephen C. Ekker, Ph.D. (@scekker) 's Twitter Profile Photo

Your comments are pretty harsh when it comes to Ziopharm. They were trying to make a true virus-free and scalable Car-T product for solid tumors. The SB science is absolutely real. The health market they picked was very hard to do and is still unsolved however. Big swing.

phantomneuro (@phantom_neuro) 's Twitter Profile Photo

Join us for Capital Factory ⚙️’s #HealthSupernova on June 12 in #AustinTX! Dr. Connor Glass will present on "Phantom Neuro: Redefining Human-Machine Symbiosis" at 1:20 PM CDT. Learn more and register here: healthsupernova.com

Join us for <a href="/CapitalFactory/">Capital Factory ⚙️</a>’s #HealthSupernova on June 12 in #AustinTX! Dr. Connor Glass will present on "Phantom Neuro: Redefining Human-Machine Symbiosis" at 1:20 PM CDT. Learn more and register here: healthsupernova.com
Stephen C. Ekker, Ph.D. (@scekker) 's Twitter Profile Photo

'For many scholarly societies, selling subscriptions to the journals they publish has historically been a key source of revenue, helping subsidize other work such as advocacy and providing scholarships.' Good. Societies should not fund their work by charging libraries

Zebrafish Rock! (@zebrafishrock) 's Twitter Profile Photo

May's #DanioDigest is now active on the Node! You'll find all the latest and greatest that the #zebrafish community has to offer 😎 Be sure to check it out! (Bluesky mega-thread to follow later, for those interested) the Node 🔗 thenode.biologists.com/daniodigest-ma…

Stephen C. Ekker, Ph.D. (@scekker) 's Twitter Profile Photo

'Radiology has embraced AI enthusiastically' is trivial to disprove. Radiologists have historically pushed-back on even using for training purposes (i.e. double-checking an medical student learning how to read Xrays). Glad some are embracing it, for lower costs and better care.

Stephen C. Ekker, Ph.D. (@scekker) 's Twitter Profile Photo

The main issue with CRISPR companies has been incomplete efficacy due to using an inherently imprecise gene editing tool with delivery challenges, not off-target effects. These companies have worked on delivery but almost entirely failed to innovate on core efficacy.